CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
9.64
-0.44 (-4.37%)
At close: Nov 20, 2024, 4:00 PM
9.77
+0.13 (1.35%)
After-hours: Nov 20, 2024, 5:38 PM EST
CervoMed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 10.07 | 7.14 | - | - |
| Cost of Revenue | 14.57 | 8.44 | 1.34 | - |
| Gross Profit | -4.5 | -1.29 | -1.34 | - |
| Selling, General & Admin | 8.17 | 5.72 | 2.14 | 2.62 |
| Research & Development | - | - | - | 2.42 |
| Operating Expenses | 8.17 | 5.72 | 2.14 | 5.04 |
| Operating Income | -12.67 | -7.01 | -3.48 | -5.04 |
| Interest Expense | - | - | -0 | -0 |
| Interest & Investment Income | 1.52 | 0.22 | 0.06 | 0.02 |
| Other Non Operating Income (Expenses) | -0 | 5.42 | -2.39 | 0.74 |
| EBT Excluding Unusual Items | -11.15 | -1.37 | -5.8 | -4.28 |
| Merger & Restructuring Charges | -0.8 | -0.8 | - | - |
| Other Unusual Items | - | - | - | 0.15 |
| Pretax Income | -11.95 | -2.17 | -5.8 | -4.14 |
| Net Income | -11.95 | -2.17 | -5.8 | -4.14 |
| Net Income to Common | -11.95 | -2.17 | -5.8 | -4.14 |
| Shares Outstanding (Basic) | 7 | 3 | 1 | 5 |
| Shares Outstanding (Diluted) | 7 | 3 | 1 | 5 |
| Shares Change (YoY) | 510.12% | 413.65% | -88.49% | - |
| EPS (Basic) | -1.60 | -0.82 | -11.20 | -0.92 |
| EPS (Diluted) | -1.60 | -0.82 | -11.20 | -0.92 |
| Free Cash Flow | -11.02 | -7.45 | -2.57 | -4.13 |
| Free Cash Flow Per Share | -1.48 | -2.80 | -4.97 | -0.92 |
| Gross Margin | -44.71% | -18.11% | - | - |
| Operating Margin | -125.83% | -98.15% | - | - |
| Profit Margin | -118.68% | -30.40% | - | - |
| Free Cash Flow Margin | -109.46% | -104.27% | - | - |
| EBIT | -12.67 | -7.01 | -3.48 | -5.04 |
| EBIT Margin | -125.83% | -98.15% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.